Remember, on average 50% of every dollar sold for pharmaceuticals in the US, 50%, so 50 cents out of every dollar, goes back to the supply chain, primarily to the Pharmacy Benefit Management companies and insurers
In their statement, the FDA said they have confirmed with the drugs manufacturer (Eli Lilly and Company) that, their stated product availability and manufacturing capacity can meet the present and projected national demand. Tirzepatide is the active ingredient in the GLP-1 drug Mounjaro
Just keep in mind that results are not guaranteed
Patients who stop the medication gain back on average two thirds of the weight they had lost
Whether and when the FDA acts on a regulatory submission depends on Eli Lilly's filing timeline and Phase 3 results, neither of which is fixed as of this writing
GLP-1 receptor agonists and changes in eating behaviors and eating disorder risk: a rapid review